Benzinga - Fri, 26 Mar 2021 09:03:54 -0400
Benzinga - Tue, 16 Feb 2021 17:13:39 -0400
Benzinga - Tue, 02 Feb 2021 05:29:23 -0400
Benzinga - Mon, 01 Feb 2021 17:51:10 -0400
Benzinga - Mon, 01 Feb 2021 14:29:06 -0400
load more
Sector: Health Care.Industry: Biotechnology
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. The company is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's pipeline includes four novel drug candidates currently in development for a range of inflammatory dermatological conditions. The firm's lead product candidate, topical roflumilast, has the potential to revitalize the standard of care for plaque psoriasis, atopic dermatitis, scalp psoriasis, and seborrheic dermatitis.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-11
REV
Q4 2020Est.ActualSurprise
EPS-0.790
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ARQTArcutis Biotherapeutics5.58%1.5B

Arcutis Biotherapeutics Company Questions & Answers

Q

How do I buy Arcutis Biotherapeutics (ARQT) stock?

A

You can purchase shares of Arcutis Biotherapeutics (NASDAQ: ARQT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Arcutis Biotherapeutics's (ARQT) main competitors?

A

Other companies in Arcutis Biotherapeutics’s space includes: Precigen (NASDAQ:PGEN), Replimune Group (NASDAQ:REPL) and Sangamo Therapeutics (NASDAQ:SGMO).

Q

What is the target price for Arcutis Biotherapeutics?

A

The latest price target for Arcutis Biotherapeutics (NASDAQ: ARQT) was reported by Truist Securities on 2021-02-02. The analyst firm set a price target for 48.00 expecting ARQT to rise to within 12 months (a possible 58.63% upside). 4 analyst firms have reported ratings in the last year.

Q

How much is Arcutis Biotherapeutics (ARQT) stock ?

A

The stock price for Arcutis Biotherapeutics (NASDAQ: ARQT) is $30.26 last updated Wed Apr 21 2021 20:00:01 GMT+0000 (Coordinated Universal Time).

Q

When is the next Arcutis Biotherapeutics (ARQT) dividend?

A

There are no upcoming dividends for Arcutis Biotherapeutics.

Q

When is Arcutis Biotherapeutics (NASDAQ:ARQT) reporting earnings?

A
Arcutis Biotherapeutics’s Q1 earnings are confirmed from now on May 11, 2021.
Q

When is the upcoming split for ARQT?

A

There is no upcoming split for Arcutis Biotherapeutics.